Form 8-K - Current report:
SEC Accession No. 0001599298-24-000156
Filing Date
2024-10-30
Accepted
2024-10-30 07:06:16
Documents
53
Period of Report
2024-10-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K smmt-20241030.htm   iXBRL 8-K 32306
2 EX-99.1 a2024_prx1030xq32024earn.htm EX-99.1 40663
3 EX-99.2 a20241030q32024earningsc.htm EX-99.2 39951
7 a20241030q32024earningsc001.jpg GRAPHIC 101338
8 a20241030q32024earningsc002.jpg GRAPHIC 257945
9 a20241030q32024earningsc003.jpg GRAPHIC 124891
10 a20241030q32024earningsc004.jpg GRAPHIC 151408
11 a20241030q32024earningsc005.jpg GRAPHIC 189410
12 a20241030q32024earningsc006.jpg GRAPHIC 141040
13 a20241030q32024earningsc007.jpg GRAPHIC 128443
14 a20241030q32024earningsc008.jpg GRAPHIC 131265
15 a20241030q32024earningsc009.jpg GRAPHIC 141164
16 a20241030q32024earningsc010.jpg GRAPHIC 140510
17 a20241030q32024earningsc011.jpg GRAPHIC 141477
18 a20241030q32024earningsc012.jpg GRAPHIC 101343
19 a20241030q32024earningsc013.jpg GRAPHIC 125021
20 a20241030q32024earningsc014.jpg GRAPHIC 120397
21 a20241030q32024earningsc015.jpg GRAPHIC 131494
22 a20241030q32024earningsc016.jpg GRAPHIC 100771
23 a20241030q32024earningsc017.jpg GRAPHIC 166429
24 a20241030q32024earningsc018.jpg GRAPHIC 137641
25 a20241030q32024earningsc019.jpg GRAPHIC 124942
26 a20241030q32024earningsc020.jpg GRAPHIC 110868
27 a20241030q32024earningsc021.jpg GRAPHIC 130887
28 a20241030q32024earningsc022.jpg GRAPHIC 116951
29 a20241030q32024earningsc023.jpg GRAPHIC 101338
30 a2024_prx1030xq32024earn001.jpg GRAPHIC 208575
31 a2024_prx1030xq32024earn002.jpg GRAPHIC 218914
32 a2024_prx1030xq32024earn003.jpg GRAPHIC 280370
33 a2024_prx1030xq32024earn004.jpg GRAPHIC 223037
34 a2024_prx1030xq32024earn005.jpg GRAPHIC 195235
35 a2024_prx1030xq32024earn006.jpg GRAPHIC 265761
36 a2024_prx1030xq32024earn007.jpg GRAPHIC 227729
37 a2024_prx1030xq32024earn008.jpg GRAPHIC 200801
38 a2024_prx1030xq32024earn009.jpg GRAPHIC 112055
39 a2024_prx1030xq32024earn010.jpg GRAPHIC 62234
40 a2024_prx1030xq32024earn011.jpg GRAPHIC 157298
41 a2024_prx1030xq32024earn012.jpg GRAPHIC 89930
42 a2024_prx1030xq32024earn013.jpg GRAPHIC 153011
43 a2024_prx1030xq32024earn014.jpg GRAPHIC 189834
44 a2024_prx1030xq32024earn015.jpg GRAPHIC 93385
  Complete submission text file 0001599298-24-000156.txt   8251782

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT smmt-20241030.xsd EX-101.SCH 1788
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT smmt-20241030_lab.xml EX-101.LAB 21629
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT smmt-20241030_pre.xml EX-101.PRE 12512
55 EXTRACTED XBRL INSTANCE DOCUMENT smmt-20241030_htm.xml XML 2735
Mailing Address 601 BRICKELL KEY DRIVE SUITE 1000 MIAMI FL 33131
Business Address 601 BRICKELL KEY DRIVE SUITE 1000 MIAMI FL 33131 305-203-2034
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

EIN.: 371979717 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36866 | Film No.: 241407424
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)